Cited by 147Nutritional Studies and DietRetinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial

Open access
Díaz-López, Andrés, Babio, Nancy, Martínez-González, Miguel A., Corella, Dolores, Amor, Antonio J., Fitó, Montse, Estruch, Ramon, Arós, Fernando +10 more·2015·Diabetes Care

Abstract

OBJECTIVE: To date no clinical trials have evaluated the role of dietary patterns on the incidence of microvascular diabetes complications. We hypothesized that a nutritional intervention based on the Mediterranean diet (MedDiet) would have greater protective effect on diabetic retinopathy and nephropathy than a low-fat control diet. RESEARCH DESIGN AND METHODS: This was a post hoc analysis of a cohort of patients with type 2 diabetes participating in the PREvención con DIeta MEDiterránea (PREDIMED) study, a multicenter randomized nutritional intervention trial conducted in a population at high cardiovascular risk. Individuals with type 2 diabetes who were free of microvascular complications at enrollment (n = 3,614, aged 55–80 years) were randomly assigned to one of three dietary interventions: MedDiet supplemented with extravirgin olive oil (MedDiet+EVOO), MedDiet supplemented with mixed nuts (MedDiet+Nuts), or a low-fat control diet. Two independent outcomes were considered: new onset of diabetic retinopathy and nephropathy. Hazard ratios (HRs) were calculated using multivariable-adjusted Cox regression. RESULTS: During a median follow-up of 6.0 years, we identified 74 new cases of retinopathy and 168 of nephropathy. Compared with the control diet, multivariable-adjusted HRs for diabetic retinopathy were 0.56 (95% CI 0.32–0.97) for the MedDiet+EVOO and 0.63 (0.35–1.11) for the MedDiet+Nuts. No between-group differences were found for nephropathy. When the yearly updated information on adherence to the MedDiet was considered, the HR for retinopathy in the highest versus the lowest quintile was 0.34 (0.13–0.89; P = 0.001 for trend). No significant associations were found for nephropathy. CONCLUSIONS: A MedDiet enriched with EVOO may protect against diabetic retinopathy but not diabetic nephropathy.

Integrity signals

Registry

Crossref · 10.2337/dc15-1117

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased adherence to the Mediterranean diet has been associated with lower risk of developing diabetic retinopathy among patients with type 2 diabetes.

    “Increased adherence to MD has been associated with lower risk of developing diabetic retinopathy (HR 0.34; 95% CI 0.13 to 0.89; p = 0.001 for trend) among 3614 patients with type 2 diabetes (aged 55–80 years) from the PREvención con DIeta MEDiterránea (PREDIMED) study [70].”
  • The benefits of Mediterranean diets were greater than low-fat diets in diabetic retinopathy, but no significant differences were found in diabetic nephropathy.

    “In addition, a study has also found that the benefits of Mediterranean diets were greater than low-fat diets in diabetic retinopathy, but no significant differences were found in diabetic nephropathy (160).”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Díaz-López, A., Babio, N., Martínez-González, M. A., Corella, D., Amor, A. J., Fitó, M., Estruch, R., Arós, F., Gómez-Gracia, E., Fiol, M., Lapetra, J., Serra-Majem, L., Basora, J., Basterra-Gortari, F. J., Zanon-Moreno, V., Muñoz, M. Á., Salas-Salvadó, J., & the PREDIMED Study Investigators
Affiliations
  • Human Nutrition Unit, Biochemistry and Biotechnology Department, Faculty of Medicine and Health Sciences, Institut d'Investigació Sanitària Pere Virgili (IISPV), Rovira i Virgili University, Reus, Spain
  • Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain
  • Universitat de València (ES)
  • Instituto de Salud Carlos III (ES)
  • Andalusian Health Service (ES)
Venue
Diabetes Care
Published
2015-09-13
Volume
38
Issue
11
Pages
2134-2141
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1657804332
Cited by
147
References
42
Citations by year
2026: 9 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 8 · 2021: 18 · 2020: 15 · 2019: 20 · 2018: 14 · 2017: 13 · 2016: 10 · 2014: 1
FWCI
13.20
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • Rovira & Virgili repository (submittedVersion, cc-by)
  • Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
Mediterranean diet, diabetic retinopathy, diabetic nephropathy, microvascular complications, type 2 diabetes, dietary intervention, mixed nuts, PREDIMED trial, dietary adherence
MeSH terms
Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Male, Middle Aged, Nuts, Risk Factors, Incidence, Diet, Mediterranean, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review